Manufacturer
Takeda Pharmaceuticals
Pharmaceutical manufacturer based in Japan
Japan
- Products listed
- 130
- Molecules
- 50
- Therapy areas
- 14
Takeda Pharmaceuticals is a pharmaceutical manufacturer based in Japan. MedsAcross lists 130 of its products across 50 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- Japan
- Indian manufacturer
- No
- Also listed as
- Takeda Pharmaceuticals America, INC., Takeda Pharmaceuticals America, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Takeda Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Psychiatry
17 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Rozerem 8 mg tabletOral | Ramelteon | US FDA | Available on request |
| Trintellix 10 mg tabletOral | Vortioxetine | US FDA | Available on request |
| Trintellix 20 mg tabletOral | Vortioxetine | US FDA | Available on request |
| Trintellix 5 mg tabletOral | Vortioxetine | US FDA | Available on request |
| Vyvanse 10 mg capsuleOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 10 mg chewable tabletOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 20 mg capsuleOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 20 mg chewable tabletOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 30 mg chewable tabletOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 30 mg capsuleOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 40 mg capsuleOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 40 mg chewable tabletOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 50 mg chewable tabletOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 50 mg capsuleOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 60 mg chewable tabletOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 60 mg capsuleOral | Lisdexamfetamine | US FDA | Available on request |
| Vyvanse 70 mg capsuleOral | Lisdexamfetamine | US FDA | Available on request |
Diabetes
15 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Actoplus Met 850 mg/15 mg tabletOral | Metformin and Pioglitazone | US FDA | Available on request |
| Actos 15 mg tabletOral | Pioglitazone | US FDA | Available on request |
| Actos 30 mg tabletOral | Pioglitazone | US FDA | Available on request |
| Actos 45 mg tabletOral | Pioglitazone | US FDA | Available on request |
| Duetact 2 mg/30 mg tabletOral | Glimepiride and Pioglitazone | US FDA | Available on request |
| Duetact 4 mg/30 mg tabletOral | Glimepiride and Pioglitazone | US FDA | Available on request |
| Kazano 12.5 mg/1000 mg tabletOral | Alogliptin and Metformin | US FDA | Available on request |
| Kazano 12.5 mg/500 mg tabletOral | Alogliptin and Metformin | US FDA | Available on request |
| Nesina 12.5 mg tabletOral | Alogliptin | US FDA | Available on request |
| Nesina 25 mg tabletOral | Alogliptin | US FDA | Available on request |
| Nesina 6.25 mg tabletOral | Alogliptin | US FDA | Available on request |
| Oseni 12.5 mg/30 mg tabletOral | Alogliptin and Pioglitazone | US FDA | Available on request |
| Oseni 25 mg/15 mg tabletOral | Alogliptin and Pioglitazone | US FDA | Available on request |
| Oseni 25 mg/30 mg tabletOral | Alogliptin and Pioglitazone | US FDA | Available on request |
| Oseni 25 mg/45 mg tabletOral | Alogliptin and Pioglitazone | US FDA | Available on request |
Oncology
15 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Agrylin 0.5 mg capsuleOral | Anagrelide | US FDA | Available on request |
| Alunbrig kit | Brigatinib | US FDA | Available on request |
| Alunbrig 180 mg tabletOral | Brigatinib | US FDA | Available on request |
| Alunbrig 30 mg tabletOral | Brigatinib | US FDA | Available on request |
| Alunbrig 90 mg tabletOral | Brigatinib | US FDA | Available on request |
| Fruzaqla 1 mg capsuleOral | Fruquintinib | US FDA | Available on request |
| Fruzaqla 5 mg capsuleOral | Fruquintinib | US FDA | Available on request |
| Iclusig 10 mg tabletOral | Ponatinib | US FDA | Available on request |
| Iclusig 15 mg tabletOral | Ponatinib | US FDA | Available on request |
| Iclusig 30 mg tabletOral | Ponatinib | US FDA | Available on request |
| Iclusig 45 mg tabletOral | Ponatinib | US FDA | Available on request |
| Ninlaro 2.3 mg capsuleOral | Ixazomib | US FDA | Available on request |
| Ninlaro 3 mg capsuleOral | Ixazomib | US FDA | Available on request |
| Ninlaro 4 mg capsuleOral | Ixazomib | US FDA | Available on request |
| Velcade 3.5 mg powder for injectionIntravenous, subcutaneous | Bortezomib | US FDA | Available on request |
Immunoglobulins
13 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Cuvitru 1000 mg/5 mL injectionSubcutaneous Cold chain | Human immunoglobulin g | US FDA | Available on request |
| Cuvitru 10000 mg/50 mL injectionSubcutaneous Cold chain | Human immunoglobulin g | US FDA | Available on request |
| Cuvitru 2000 mg/10 mL injectionSubcutaneous Cold chain | Human immunoglobulin g | US FDA | Available on request |
| Cuvitru 4000 mg/20 mL injectionSubcutaneous Cold chain | Human immunoglobulin g | US FDA | Available on request |
| Cuvitru 8000 mg/40 mL injectionSubcutaneous Cold chain | Human immunoglobulin g | US FDA | Available on request |
| GAMMAGARD Liquid 1000 mg/10 mL injectionIntravenous, subcutaneous | Human immunoglobulin g | US FDA | Available on request |
| GAMMAGARD Liquid 10000 mg/100 mL injectionIntravenous, subcutaneous | Human immunoglobulin g | US FDA | Available on request |
| GAMMAGARD Liquid 20000 mg/200 mL injectionIntravenous, subcutaneous | Human immunoglobulin g | US FDA | Available on request |
| GAMMAGARD Liquid 2500 mg/25 mL injectionIntravenous, subcutaneous | Human immunoglobulin g | US FDA | Available on request |
| GAMMAGARD Liquid 30000 mg/300 mL injectionIntravenous, subcutaneous | Human immunoglobulin g | US FDA | Available on request |
| GAMMAGARD Liquid 5000 mg/50 mL injectionIntravenous, subcutaneous | Human immunoglobulin g | US FDA | Available on request |
| GAMMAGARD Liquid ERC 10000 mg/100 mL injectionIntravenous, subcutaneous Cold chain | Human immunoglobulin g | US FDA | Available on request |
| GAMMAGARD Liquid ERC 5000 mg/50 mL injectionIntravenous, subcutaneous Cold chain | Human immunoglobulin g | US FDA | Available on request |
Gastroenterology
12 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Amitiza 24 mcg capsuleOral | Lubiprostone | US FDA | Available on request |
| Dexilant 30 mg delayed-release capsuleOral | Dexlansoprazole | US FDA | Available on request |
| Dexilant 60 mg delayed-release capsuleOral | Dexlansoprazole | US FDA | Available on request |
| Lialda 1.2 g delayed-release tabletOral | Mesalamine | US FDA | Available on request |
| Mesalamine 1.2 g delayed-release tabletOralGeneric name | Mesalamine | US FDA | Available on request |
| Motegrity 1 mg tabletOral | Prucalopride | US FDA | Available on request |
| Motegrity 2 mg tabletOral | Prucalopride | US FDA | Available on request |
| Pentasa 250 mg capsuleOral | Mesalamine | US FDA | Available on request |
| Pentasa 500 mg capsuleOral | Mesalamine | US FDA | Available on request |
| Prevacid 30 mg delayed-release capsuleOral | Lansoprazole | US FDA | Available on request |
| Prevacid SoluTab 15 mg delayed-release orally disintegrating tabletOral | Lansoprazole | US FDA | Available on request |
| Prevacid SoluTab 30 mg delayed-release orally disintegrating tabletOral | Lansoprazole | US FDA | Available on request |
Nephrology and urology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Fosrenol 1000 mg oral powderOral | Lanthanum carbonate | US FDA | Available on request |
| Fosrenol 1000 mg chewable tabletOral | Lanthanum carbonate | US FDA | Available on request |
| Fosrenol 500 mg chewable tabletOral | Lanthanum carbonate | US FDA | Available on request |
| Fosrenol 750 mg oral powderOral | Lanthanum carbonate | US FDA | Available on request |
| Fosrenol 750 mg chewable tabletOral | Lanthanum carbonate | US FDA | Available on request |
Rare diseases and enzyme replacement
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Elaprase 6 mg/3 mL injectionIntravenous Cold chain | Idursulfase | US FDA | Available on request |
| Gattex kit Cold chain | Teduglutide | US FDA | Available on request |
| Gattex 5 mg/0.5 mL powder for injectionSubcutaneous Cold chain | Teduglutide | US FDA | Available on request |
| Vpriv 2.5 mg/mL powder for injectionIntravenous Cold chain | Velaglucerase alfa | US FDA | Available on request |
Haematology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Firazyr 30 mg/3 mL injectionSubcutaneous | Icatibant | US FDA | Available on request |
| Kalbitor 10 mg/1 mL injectionSubcutaneous Cold chain | Ecallantide | US FDA | Available on request |
| Takhzyro 150 mg/1 mL injectionSubcutaneous Cold chain | Lanadelumab | US FDA | Available on request |
| Takhzyro 300 mg/2 mL injectionSubcutaneous Cold chain | Lanadelumab | US FDA | Available on request |
Cardiology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Intuniv 1 mg extended-release tabletOral | Guanfacine | US FDA | Available on request |
| Intuniv 2 mg extended-release tabletOral | Guanfacine | US FDA | Available on request |
| Intuniv 3 mg extended-release tabletOral | Guanfacine | US FDA | Available on request |
| Intuniv 4 mg extended-release tabletOral | Guanfacine | US FDA | Available on request |
Neurology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Carbatrol 100 mg extended-release capsuleOral | Carbamazepine | US FDA | Available on request |
| Carbatrol 200 mg extended-release capsuleOral | Carbamazepine | US FDA | Available on request |
| Carbatrol 300 mg extended-release capsuleOral | Carbamazepine | US FDA | Available on request |
Immunology and transplant
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Entyvio 108 mg/0.68 mL injectionSubcutaneous Cold chain | Vedolizumab | US FDA | Available on request |
| Entyvio 300 mg/5 mL powder for injectionIntravenous Cold chain | Vedolizumab | US FDA | Available on request |
| ENTYVIO Pen 108 mg/0.68 mL injectionSubcutaneous Cold chain | Vedolizumab | US FDA | Available on request |
Rheumatology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Uloric 40 mg tabletOral | Febuxostat | US FDA | Available on request |
| Uloric 80 mg tabletOral | Febuxostat | US FDA | Available on request |
Respiratory
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Eohilia 2 mg/10 mL oral suspensionOral Cold chain | Budesonide | US FDA | Available on request |
HIV
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Livtencity 200 mg tabletOral | Maribavir | US FDA | Available on request |
Other products
31 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Adderall XR 1.25 mg/1.25 mg/1.25 mg/1.25 mg extended-release capsuleOral | Amphetamine and Dextroamphetamine | US FDA | Available on request |
| Adderall XR 2.5 mg/2.5 mg/2.5 mg/2.5 mg extended-release capsuleOral | Amphetamine and Dextroamphetamine | US FDA | Available on request |
| Adderall XR 3.75 mg/3.75 mg/3.75 mg/3.75 mg extended-release capsuleOral | Amphetamine and Dextroamphetamine | US FDA | Available on request |
| Adderall XR 5 mg/5 mg/5 mg/5 mg extended-release capsuleOral | Amphetamine and Dextroamphetamine | US FDA | Available on request |
| Adderall XR 6.25 mg/6.25 mg/6.25 mg/6.25 mg extended-release capsuleOral | Amphetamine and Dextroamphetamine | US FDA | Available on request |
| Adderall XR 7.5 mg/7.5 mg/7.5 mg/7.5 mg extended-release capsuleOral | Amphetamine and Dextroamphetamine | US FDA | Available on request |
| Advate kit Cold chain | Antihemophilic factor | US FDA | Available on request |
| Adzynma kit Cold chain | Apadamtase alfa | US FDA | Available on request |
| Aralast NP kit | Alpha-1-proteinase inhibitor | US FDA | Available on request |
| Ceprotin kit | Protein c concentrate human | US FDA | Available on request |
| Cinryze kit | Human c1-esterase inhibitor | US FDA | Available on request |
| Cinryze 500 IU/5 mL powder for injectionIntravenous | Human c1-esterase inhibitor | US FDA | Available on request |
| Feiba kit Cold chain | Anti-inhibitor coagulant complex | US FDA | Available on request |
| Flexbumin 12.5 g/250 mL injectionIntravenous | Albumin human | US FDA | Available on request |
| Flexbumin 12.5 g/50 mL injectionIntravenous | Albumin human | US FDA | Available on request |
| Flexbumin 25 g/100 mL injectionIntravenous | Albumin human | US FDA | Available on request |
| Gammagard S/D kit | Immune globulin intravenous | US FDA | Available on request |
| Glassia 1 g/50 mL injectionIntravenous Cold chain | .alpha.1-proteinase inhibitor human | US FDA | Available on request |
| Glassia 4 g/200 mL injectionIntravenous Cold chain | .alpha.1-proteinase inhibitor human | US FDA | Available on request |
| Glassia 5 g/250 mL injectionIntravenous Cold chain | .alpha.1-proteinase inhibitor human | US FDA | Available on request |
| Hemofil M kit Cold chain | Antihemophilic factor human | US FDA | Available on request |
| Hyqvia kit Cold chain | Immune globulin infusion | US FDA | Available on request |
| Mimrylo kitSubcutaneous | Rusfertide | US FDA | Available on request |
| Mydayis 12.5 mg/12.5 mg/12.5 mg/12.5 mg extended-release capsuleOral | Amphetamine and Dextroamphetamine | US FDA | Available on request |
| Mydayis 3.125 mg/3.125 mg/3.125 mg/3.125 mg extended-release capsuleOral | Amphetamine and Dextroamphetamine | US FDA | Available on request |
| Mydayis 6.25 mg/6.25 mg/6.25 mg/6.25 mg extended-release capsuleOral | Amphetamine and Dextroamphetamine | US FDA | Available on request |
| Mydayis 9.375 mg/9.375 mg/9.375 mg/9.375 mg extended-release capsuleOral | Amphetamine and Dextroamphetamine | US FDA | Available on request |
| Obizur kit Cold chain | Antihemophilic factor | US FDA | Available on request |
| Recombinate kit Cold chain | Antihemophilic factor recombinant | US FDA | Available on request |
| Rixubis kit Cold chain | Coagulation factor ix | US FDA | Available on request |
| Vonvendi kit Cold chain | Von willebrand factor | US FDA | Available on request |
Molecules made
Metformin and PioglitazonePioglitazoneAmphetamine and DextroamphetamineAntihemophilic factorApadamtase alfaAnagrelideBrigatinibLubiprostoneAlpha-1-proteinase inhibitorCarbamazepineProtein c concentrate humanHuman c1-esterase inhibitorHuman immunoglobulin gDexlansoprazoleGlimepiride and PioglitazoneIdursulfaseVedolizumabBudesonideAnti-inhibitor coagulant complexIcatibantAlbumin humanLanthanum carbonateFruquintinibImmune globulin intravenousTeduglutide.alpha.1-proteinase inhibitor humanAntihemophilic factor humanImmune globulin infusionPonatinibGuanfacineEcallantideAlogliptin and MetforminMesalamineMaribavirRusfertidePrucaloprideAlogliptinIxazomibAlogliptin and PioglitazoneLansoprazoleAntihemophilic factor recombinantCoagulation factor ixRamelteonLanadelumabVortioxetineFebuxostatBortezomibVon willebrand factorVelaglucerase alfaLisdexamfetamine
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Takeda Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.